Welcome to your source of quality news, articles, analysis and latest data.

Complete information on:

DOSIK HEMATOLOGY AND ONCOLOGY, P.C.

Company data, financial data, shareholder information and contact data
Name:DOSIK HEMATOLOGY AND ONCOLOGY, P.C.
Company number:4258852
Company status:Active
Incorporation date:14 June 2012 (almost 9 years ago)
-
Company type:DOMESTIC PROFESSIONAL CORPORATION
Jurisdiction:New York (US)
Business number:unavailable
Registered address:400 GARDEN CITY PLAZA, STE. 202, GARDEN CITY, 11530, NEW YORK, United States
Agent name:unavailable
Previous names:DOSIK HEMATOLOGY AND ONCOLOGY, P.C.
Company addresses:Head Office Address DOSIK HEMATOLOGY AND ONCOLOGY, P.C, 500 4-TH AVENUE, SUITE 1, BROOKLYN, NEW YORK, 11215
Latest events:2019-12-05 - 2020-01-06 Removal of officer DOSIK HEMATOLOGY AND ONCOLOGY, P.C, principal executive office
2021-02-16 - 2021-03-01 Addition of officer ROBERT PRESS, M.D., PH.D, chief executive officer
2021-03-01 - 2021-04-01 Removal of officer DAVID DOSIK, chief executive officer
Officers:ATTN: MARC L. HAMROFF, ESQ., MORRITT HOCK & HAMROFF LLP ESQ.
ROBERT PRESS, M.D., PH.D M.D.
Officers:
Name:

ATTN: MARC L. HAMROFF, ESQ., MORRITT HOCK & HAMROFF LLP, Position: ESQ.

Name:

ROBERT PRESS, M.D., PH.D, Position: M.D.

Do you want to contact ROBERT PRESS, M.D., PH.D? We found following contact data in our database:
Other companies:
All information found on this page is extracted from public sources and should not be used in any official way.